BioSyent Inc.
BIOYF
$8.50
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.61% | -3.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.61% | -3.83% | |||
| Cost of Revenue | 30.95% | -11.00% | |||
| Gross Profit | 17.65% | -1.55% | |||
| SG&A Expenses | 9.28% | 4.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.72% | -0.90% | |||
| Operating Income | 35.26% | -11.63% | |||
| Income Before Tax | 33.51% | -9.76% | |||
| Income Tax Expenses | 33.52% | -9.76% | |||
| Earnings from Continuing Operations | 33.51% | -9.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.51% | -9.76% | |||
| EBIT | 35.26% | -11.63% | |||
| EBITDA | 37.60% | -12.61% | |||
| EPS Basic | 33.41% | -9.62% | |||
| Normalized Basic EPS | 33.48% | -9.67% | |||
| EPS Diluted | 33.02% | -9.21% | |||
| Normalized Diluted EPS | 33.46% | -9.63% | |||
| Average Basic Shares Outstanding | 0.05% | -0.13% | |||
| Average Diluted Shares Outstanding | 0.04% | -0.15% | |||
| Dividend Per Share | 0.55% | 3.74% | |||
| Payout Ratio | -0.25% | 0.15% | |||